Call for Abstract

15th World Congress on Biotechnology and
Biotech Industries Meet, will be organized around the theme “Meeting the Global Challenges through Biotechnology”

Biotech Congress 2017 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Biotech Congress 2017

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Biotechnology is an innovative science in which living systems and organisms are used to develop new and useful products, ranging from healthcare products to seeds. The field of Biotechnology is growing rapidly making tremendous impacts in Medical/Health Care, Food & Agriculture. The Global Biotechnology industry is in the growth phase of its economic life cycle. Over the five years to 2014, revenue and industry value added (IVA) growth have outpaced world GDP growth. The Frontiers in Biotechnology track will cover current technological aspects that aim at obtaining products with scientific, industrial, health and agricultural applications, from organisms with increasing levels of complexity from bacteria, yeast, plants, animal cells and virus. With the lectures and demonstrations on stem cell therapy, Embryo transfer technology, next generation sequencing, Drug discovery, biotechnology in food and dairy, etc... The participants are expected to acquire knowledge in techniques and methodologies used in Biotechnology.

 

  • Track 1-1Stem cell therapy
  • Track 1-2Next generation sequencing
  • Track 1-3Personalized medicine
  • Track 1-4DNA, tissue chips & micro array technologies
  • Track 1-5Zika virus and global food security
  • Track 1-6Embryo transfer technology

Biotechnology has application in four major industrial areas, including health care (medical), crop production and agriculture, non food (industrial) uses of crops and other products (e.g. biodegradable plastics, vegetable oil, biofuels), and environmental uses.Applied Microbiology and Biotechnology focusses on prokaryotic or eukaryotic cells, relevant enzymes and proteins, applied genetics and molecular biotechnology, genomics and proteomics, applied microbial and cell physiology, environmental biotechnology, process and products and more.

Approximately 120 companies have been identified to be involved in animal biotechnology and are profiled in the report. These are a mix of animal healthcare companies and biotechnology companies. Top companies in this area are identified and ranked. Information is given about the research activities of 11 veterinary and livestock research institutes. Important 108 collaborations in this area are shown.

 

  • Track 2-1Protein engineering
  • Track 2-2Cloning, recombinant selection and expression
  • Track 2-3Molecular farming
  • Track 2-4Trangenics and gene therapy
  • Track 2-5Forensic sciences
  • Track 2-6Tools and techniques of molecular Biology
  • Track 2-7Cellular & tissue engineering
  • Track 2-8Biotechnology and bioprocessing
  • Track 2-9Tissue culture

Pharmaceutical Biotechnology is the science that covers all technologies required for producing, manufacturing and registration of biological drugs. Pharmaceutical Biotechnology is an increasingly important area of science and technology. It contributes in design and delivery of new therapeutic drugs, diagnostic agents for medical tests, and in gene therapy for correcting the medical symptoms of hereditary diseases. The Pharmaceutical Biotechnology is widely spread, ranging from many ethical issues to changes in healthcare practices and a significant contribution to the development of national economy. Biopharmaceuticals consists of large biological molecules which are proteins. They target the underlying mechanisms and pathways of a disease or ailment; it is a relatively young industry. They can deal with targets in humans that are not accessible with traditional medicines.

  • Track 3-1Drug delivery
  • Track 3-2Biopharmaceuticals
  • Track 3-3Personalized medicine
  • Track 3-4Biomarkers
  • Track 3-5Vaccines and antibiotics
  • Track 3-6Forensic medicine
  • Track 3-7Clinical research/Clinical trials
  • Track 3-8Neutraceuticals
  • Track 3-9Cosmoceuticals

Medical biotechnology refers to a medicinal or diagnostic product or a vaccine that consists of or has been produced in living organisms and may be manufactured via recombinant. Medical Biotechnology  has a tremendous impact on meeting the needs of patients and their families as it not only encompasses medicines and diagnostics that are manufactured using a biotechnological process, but also gene and cell therapies and tissue engineered products. Today, the majority of innovative medicines, whether manufactured using biotechnology or via a chemical synthesis like a traditional small molecule medicine, as well as many diagnostic products, are made available by applying modern biotechnology in their development and manufacturing.

 

  • Track 4-1Tissue engineering & regenerative medicine
  • Track 4-2Gene therapy
  • Track 4-3Cloning
  • Track 4-4Pharmacogenomics

Food biotechnology encompasses the use of living organisms to make products, to improve plants or animals, or to develop microbes for specific uses. It includes genetically modified (GM) crops, functional foods, aquaculture as well as more traditional food products such as cheeses, breads and beer. It is estimated that in the next 20-30 years demand for food will increase by 70%. Biotechnology will be key to meeting this demand. In the US there is a general public acceptance of biotech-enabled innovation in food and in North America, more than 60% of all processed food products are reported to contain GM ingredients. Consumer resistance to GM crop and foods containing GM ingredients remains high in Europe and there are significant regulatory constraints.

 

  • Track 5-1Advances in food biotechnology
  • Track 5-2Functional food and dietary supplements
  • Track 5-3Development of probiotics and prebiotics
  • Track 5-4Detection and control of foodborne pathogens
  • Track 5-5Biotechnology-derived enzymes for food applications
  • Track 5-6Biotechnology for food safety and bio-process engineering
  • Track 5-7Biotechnology for new and better quality food
  • Track 5-8Biotechnology for milk and dairy Products
  • Track 5-9Biotechnology of food traceability
  • Track 5-10Biotechnology for food processing, packaging and quality Control
  • Track 5-11GMOs and food security issues

Agricultural biotechnology is a collection of scientific techniques used to improve plants, animals and microorganisms. Based on an understanding of DNA, scientists have developed solutions to increase agricultural productivity. Agricultural biotechnology is an area of agricultural science involving the use of scientific tools and techniques, including genetic engineering, molecular markers, molecular diagnostics, vaccines, and tissue culture, to modify living organisms: plants, animals, and microorganisms. It also includes Transgenic Crops, Plant agriculture, Animal agriculture, Orgainc agriculture, Tissue culture, Food processing. Advances in science, many of them from scientists at USDA or through research funded by USDA, have opened up new options for farmers responding to market needs and environmental challenges.

 

  • Track 6-1Genetically engineered crops
  • Track 6-2Biofertilisers
  • Track 6-3Biologic control and bioestimulants of crops
  • Track 6-4Transgenic plants
  • Track 6-5Emerging technologies in agriculture and livestock
  • Track 6-6Tissue culture
  • Track 6-7Green house farming
  • Track 6-8Organic agriculture
  • Track 6-9Weed mangement

It improves the food we eat - meat, milk and eggs. Biotechnology can improve an animal’s impact on the environment. Animal biotechnology is the use of science and engineering to modify living organisms. The goal is to make products, to improve animals and to develop microorganisms for specific agricultural uses. It  enhances the ability to detect, treat and prevent diseases, include creating transgenic animals (animals with one or more genes introduced by human intervention), using gene knock out technology to make animals with a specific inactivated gene and producing nearly identical animals by somatic cell nuclear transfer (or cloning).

Approximately 120 companies have been identified to be involved in animal biotechnology and are profiled in the report. These are a mix of animal healthcare companies and biotechnology companies. Top companies in this area are identified and ranked. Information is given about the research activities of 11 veterinary and livestock research institutes. Important 108 collaborations in this area are shown.

 

  • Track 7-1Animal tissue culture
  • Track 7-2Ethical Issues in animal biotechnology
  • Track 7-3Transgenic animals and their applications
  • Track 7-4Fisheries
  • Track 7-5Gene editing in livestock: technology, and application
  • Track 7-6Cell based therapy
  • Track 7-7Epigenetics and animal health
  • Track 7-8Meat and allied industries
  • Track 7-9Animal genomics
  • Track 7-10Animal breeding
  • Track 7-11Animal cloning
  • Track 7-12Embryo genomics

Industrial biotechnology   is the application of biotechnology for industrial purposes, including industrial fermentation.  The practice of using cells such as micro-organisms, or components of cells like enzymes, to generate industrially useful products in sectors such as chemicals, food and feed, detergents, paper and pulp, textiles and biofuels. Industrial Biotechnology offers a premier forum bridging basic research and R&D with later-stage commercialization for sustainable bio based industrial and environmental applications.

An increasing number of chemicals and materials, like base chemicals, polymers, industrial catalysts, enzymes and detergents are produced using biotechnology. In 2010, the sales of industrial chemicals created using biotechnology in at least one step of the production process equalled €92bn globally, and this is expected to increase to €228bn by 2015.

 

  • Track 8-1Industrial enzymes
  • Track 8-2Biomass technology
  • Track 8-3Bioenergy transition
  • Track 8-4Renewable energy
  • Track 8-5Biopolymers
  • Track 8-6Algae
  • Track 8-7Advanced biofuels
  • Track 8-8Renewable chemicals & biobased materials
  • Track 8-9Enzyme technology
  • Track 8-10Bioactives
  • Track 8-11Food and beverage fermentation
  • Track 8-12Biogas

The  biotechnology that is applied  and used to study the natural environment. Environmental biotechnology could also imply that one try to harness biological process for commercial uses and exploitation. Environmental biotechnology as "the development, use and regulation of biological systems for remediation of contaminated environments  and for environment-friendly processes (green manufacturing technologies and sustainable development). Environmental biotechnology can simply be described as "the optimal use of nature, in the form of plants, animals, bacteria, fungi and algae, to produce renewable energy, food and nutrients in a synergistic integrated cycle of profit making processes where the waste of each process becomes the feedstock for another process".

U.S. sales of environmental  biotechnology products was valued at $241.2 million in 2012. This is expected to increase at a total compound annual growth rate (CAGR) of 7.9%, with 2013 sales of $261.9 million, rising to $382.3 million in 2018.

 

  • Track 9-1Biotechnology in reducing the use of chemical pesticides, herbicides and fertilizers
  • Track 9-2Biotechnology for treatment of industrial effluents
  • Track 9-3Biotechnology for toxic site reclamation
  • Track 9-4Biotechnology in restoration of degraded lands
  • Track 9-5Bioremediation & biodegradation

Nano biotechnology refers to the intersection of nanotechnology and biology. Given that the subject is one that has only emerged very recently, Bio nanotechnology and Nano biotechnology serve as blanket terms for various related technologies. The most important objectives that are frequently found in Nano biology involve applying Nano tools to relevant medical/biological problems and refining these applications. Developing new tools, such as peptoid Nano-sheets, for medical and biological purposes is another primary objective in nanotechnology. New Nano-tools are often made by refining the applications of the Nano-tools that are already being used. The imaging of native biomolecules, biological membranes, and tissues is also a major topic for the Nano-biology researchers. Other topics concerning Nano biology include the use of cantilever array sensors and the application of Nano-photonics for manipulating molecular processes in living cells.

 

  • Track 10-1Advances in nano biotechnology
  • Track 10-2Nano-biosensors
  • Track 10-3Nanocarrier-formulations
  • Track 10-4Nanocomposites
  • Track 10-5Nanofarming
  • Track 10-6Nanoparticles
  • Track 10-7Nanophotonics

Aquaculture & Marine Biotechnology have been the subject of great importance not only because of the sustainable utilization of their resources to feed the billion people of the world but also for the future challenges for discovery of new products and process development of economic importance through its treasure recognition and diversification. Apart from contributing to high quality and healthy food (aquaculture), nutraceuticals and medicinal products (anti-cancer and antimicrobials), this sector is expected to contribute to sustainable alternative source of energy (biofuel from microalgae) and environmental health. The potential for the contribution of Marine Biotechnology is, therefore, even more relevant now than it was ten years ago and a sound strategy for its development in India is urgently needed to allow this potential to be realized. Marine Biotechnology is capable of making an important contribution towards meeting impending challenges like a sustainable supply of food and energy and human health. Marine Biotechnology is providing many new solutions to Industry and Agriculture, including environmentally friendly pesticides and salt-resistant enzymes that are helpful in many industrial applications.

 

  • Track 11-1Diversity of marine phototorophs
  • Track 11-2Marine fungal diversity and bioprospecting
  • Track 11-3Marine microalgae
  • Track 11-4Marine viruses

Molecular biotechnology is the use of laboratory techniques to study and modify nucleic acids and proteins for applications in areas such as human and animal health, agriculture, and the environment.  Molecular biotechnology results from the convergence of many areas of research, such as molecular biology, microbiology, biochemistry, immunology, genetics, and cell biology.  It is an exciting field fueled by the ability to transfer genetic information between organisms with the goal of understanding important biological processes or creating a useful product.

The key drivers for molecular biology enzymes, kits and reagents market are the rising R&D expenditure by the pharmaceutical and biotech companies, and increasing public funding for life science research. The World Health Organization estimates that the total aged population may rise from 605 million in 2000 (11% of the global population) to 2 billion by 2050, accounting for 22% of the global population.

  • Track 12-1Recent advances in molecular biotechnology
  • Track 12-2Molecular biotechnology for textiles manufacturing
  • Track 12-3Molecular biotechnology for forestry

Microorganisms have been exploited for their specific biochemical and physiological properties from the earliest times for baking, brewing, and food preservation and more recently for producing antibiotics, solvents, amino acids, feed supplements, and chemical feedstuffs. Over time, there has been continuous selection by scientists of special strains of microorganisms, based on their efficiency to perform a desired function. Progress, however, has been slow, often difficult to explain, and hard to repeat.
Recent developments in molecular biology and genetic engineering could provide novel solutions to long-standing problems. Over the past decade, scientists have developed the techniques to move a gene from one organism to another, based on discoveries of how cells store, duplicate, and transfer genetic information.

 

  • Track 13-1New approches to enzyme and microbial technology
  • Track 13-2Microbial engineering for production of chemicals and pharmaceuticals
  • Track 13-3Microbial physiology, metabolism and gene expression
  • Track 14-1Biotechnology for improvement of yield and quality traits
  • Track 14-2Breeding biotechnologies
  • Track 14-3Plant germplasm
  • Track 14-4Commercial, legal, sociological, and public aspects of Plant Biotechnologies
  • Track 14-5IPR & plant variety protection rights

One kind of biotechnology is gene technology, sometimes called 'genetic engineering' or 'genetic modification', where the genetic material of living things is deliberately altered to enhance or remove a particular trait and allow the organism to perform new functions. Genes within a species can be modified, or genes can be moved from one species to another.

The largest market today in comparison with non-genetic tests is the developed nations of the North Americas, Europe and Australia. Among these, North America accounts for the largest market share and expected to lead the market during the entire forecast period of 2013 to 2019. However, Asia-Pacific region is expected to show an attractive growth rate in coming years.

  • Track 16-1Management in biotechnology
  • Track 16-2International market access
  • Track 16-3Therapeutic discovery project credit
  • Track 16-4Technology transfer

From agriculture to environmental science, biotechnology plays an important role in improving industry standards, services, and developing new products. Biotechnology involves the spectrum of life science-based research companies working on transformative technologies for a wide range of industries. While agriculture, material science and environmental science are major areas of research, the largest impact is made in the field medicine. As a large player in the research and development of pharmaceuticals, the role of biotechnology in the healthcare field is undeniable. From genetically analysis and manipulation to the formation of new drugs, many biotech firms are transforming into pharmaceutical and biopharmaceutical leaders.

 
  • Track 18-1Biotechnology market in europe
  • Track 18-2Biotechnology market in usa
  • Track 18-3Biotechnology market in asia
  • Track 18-4Biotechnology market in australia
  • Track 18-5Biotechnology market in africa
  • Track 19-1Biotechnology in europe
  • Track 19-2Biotech companies in Italy and their market analysis
  • Track 19-3Biotech companies in uk and their market analysis

Every new business needs some startup capital, for research, product development and production, permits and licensing and other overhead costs, in addition to what is needed to pay your staff, if you have any. Biotechnology products arise from successful biotech companies. These companies are built by talented individuals in possession of a scientific breakthrough that is translated into a product or service idea, which is ultimately brought into commercialization. At the heart of this effort is the biotech entrepreneur, who forms the company with a vision they believe will benefit the lives and health of countless individuals. Entrepreneurs start biotechnology companies for various reasons, but creating revolutionary products and tools that impact the lives of potentially millions of people is one of the fundamental reasons why all entrepreneurs start biotechnology companies.

 

  • Track 20-1Capital formation
  • Track 20-2Biotech funding & grants

The Biotechnology Investor & partnering Forum conclave is one of the unique conclave focused on the management and economics of biotechnology which became so important as the field is growing on a fast paced. From agriculture and environment sectors to pharmaceutical and healthcare products and services, the industries and institutions emerging from the biotech revolution Bio-Based Economy represent one of the largest and most steadily growing building blocks of the Global economy. The social impact is overwhelming, generating tremendous progress in quality of life but also difficult issues that needs responsible management based on consumer & bio-industry perspective, solid ethical principles, growing intellectual property rights complexity, long drug development times, Bio security, unusual market structures and highly unpredictable outcomes are just some of the challenges facing biotechnology management today.

 

  • Track 21-1Angel investors and private investors
  • Track 21-2Strategic Partnering